E-Dissertationen: Search
Now showing items 1-1 of 1
An anti-CD30 immunocytokine with combined IL-2 and IL-12 domains enhances anti-tumour immunity
(2010-09-24)
Classical Hodgkin’s lymphoma is one of the most curable cancers today. However, non-responders, tumour relapses and long-term toxicities of the treatment make it necessary to look for alternative drugs. In this study, we ...